Wenjing Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wenjing Jiang has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Xin Ma
Center for Robotics, School of Control Science and Engineering, Shandong University, Jinan, China
7 shared publications Fanzun Meng
Department of Geriatric Medicine & Laboratory of Gerontology and Anti-Aging Research, Qilu Hospital of Shandong University
4 shared publicationsJun Ma
4 shared publicationsFangchun Huang
3 shared publicationsHaiyun Li
3 shared publicationsHaoyu Tian
School of Information Science and Technology, Qingdao University of Science and Technology, Qingdao, China
3 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 18, 1-2
Beyond Sleep Perception: Does the Largest WASO Bias Reflect Impaired Memory Rather Than Blunted Perception? [Response to Letter]
Response to Letter in regards to Beyond Sleep Perception: Does the Largest WASO Bias Reflect Impaired Memory Rather Than Blunted Perception? [Letter]
- 1 October 2026
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 18, 1-2
Open AccessBeyond Sleep Perception: Does the Largest WASO Bias Reflect Impaired Memory Rather Than Blunted Perception? [Response to Letter]
Response to Letter in regards to Beyond Sleep Perception: Does the Largest WASO Bias Reflect Impaired Memory Rather Than Blunted Perception? [Letter]
- Open Access
- 16 September 2026
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 20, 1921946
EEG functional connectivity for Parkinson’s disease diagnosis and non-motor symptom prediction: a machine learning approach
Introduction: Parkinson’s disease (PD) is associated with severe non-motor symptoms, including mood disorders and sleep disturbances, whose neural mechanisms are linked to dysfunction in large-scale brain networks. Functional connectivity measured by electroencephalography (EEG) can noninvasively map abnormalities at the network level. Methods: This study employed the debiased weighted phase lag index (dwPLI) to mitigate the effects of volumetric conductivity and investigated EEG functional connectivity in PD patients ( n = 14) and healthy controls ( n = 14) during resting and emotional states. Diagnostic performance was evaluated using L1-regularized logistic regression combined with a strict subject-level leave-one-subject-out cross-validation method. Results: The accuracy of the beta band model combining the four states reached 82.14% ( p < 0.05, permutation test), while the accuracy of the gamma band model under the eyes-open state reached 89.29% ( p < 0.01). Furthermore, theta band connectivity during the sadness state significantly predicted PSQI scores in PD patients. Discussion: These findings suggest that emotion-induced network dynamics may reflect sleep disturbances in PD, and establish EEG functional connectivity as a candidate neurophysiological biomarker for PD, with potential applications in both diagnostic classification and the assessment of non-motor symptoms, although validation in larger cohorts is still required.
- 16 September 2026
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 20, 1921946
Open AccessEEG functional connectivity for Parkinson’s disease diagnosis and non-motor symptom prediction: a machine learning approach
Introduction: Parkinson’s disease (PD) is associated with severe non-motor symptoms, including mood disorders and sleep disturbances, whose neural mechanisms are linked to dysfunction in large-scale brain networks. Functional connectivity measured by electroencephalography (EEG) can noninvasively map abnormalities at the network level. Methods: This study employed the debiased weighted phase lag index (dwPLI) to mitigate the effects of volumetric conductivity and investigated EEG functional connectivity in PD patients ( n = 14) and healthy controls ( n = 14) during resting and emotional states. Diagnostic performance was evaluated using L1-regularized logistic regression combined with a strict subject-level leave-one-subject-out cross-validation method. Results: The accuracy of the beta band model combining the four states reached 82.14% ( p < 0.05, permutation test), while the accuracy of the gamma band model under the eyes-open state reached 89.29% ( p < 0.01). Furthermore, theta band connectivity during the sadness state significantly predicted PSQI scores in PD patients. Discussion: These findings suggest that emotion-induced network dynamics may reflect sleep disturbances in PD, and establish EEG functional connectivity as a candidate neurophysiological biomarker for PD, with potential applications in both diagnostic classification and the assessment of non-motor symptoms, although validation in larger cohorts is still required.
- Open Access
- 1 June 2026
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 18, 1-16
Night-to-Night Sleep Variability Modulates Subjective Sleep Perception in Chronic Insomnia: A Multilevel Analysis
Subjective sleep perception often differs from objective sleep measures in chronic insomnia, but the role of night-to-night sleep variability remains insufficiently understood. This study examined the effects of daily within-individual sleep fluctuations and between-individual sleep variability on subjective sleep perception in patients with chronic insomnia. Fifty patients with chronic insomnia completed home-based sleep monitoring and sleep diaries for five to seven consecutive nights, yielding 312 valid nights. Sleep perception bias was defined as the difference between objective sleep parameters and subjective estimates. Sleep variability was quantified using the coefficient of variation. Linear mixed-effects models examined within-individual associations, between-individual variability effects, and cross-level interactions. Nightly objective changes in total sleep time, sleep efficiency, wake after sleep onset, and sleep onset latency were significantly associated with corresponding subjective-objective discrepancies. Subjective perception changed less than objective sleep parameters, suggesting reduced subjective responsiveness to nightly sleep changes. Between individuals, lower total sleep time variability was associated with greater bias in perceived sleep duration and sleep efficiency. Higher N2 percentage variability was associated with greater wake after sleep onset perception bias and moderated the association between objective wake time and subjective perception. These findings suggest that subjective sleep perception in chronic insomnia is influenced by nightly objective sleep changes and longer-term sleep variability. N2-related findings should be interpreted cautiously given the exploratory sleep-stage-specific analyses and portable EEG monitoring.
- 1 June 2026
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 18, 1-16
Open AccessNight-to-Night Sleep Variability Modulates Subjective Sleep Perception in Chronic Insomnia: A Multilevel Analysis
Subjective sleep perception often differs from objective sleep measures in chronic insomnia, but the role of night-to-night sleep variability remains insufficiently understood. This study examined the effects of daily within-individual sleep fluctuations and between-individual sleep variability on subjective sleep perception in patients with chronic insomnia. Fifty patients with chronic insomnia completed home-based sleep monitoring and sleep diaries for five to seven consecutive nights, yielding 312 valid nights. Sleep perception bias was defined as the difference between objective sleep parameters and subjective estimates. Sleep variability was quantified using the coefficient of variation. Linear mixed-effects models examined within-individual associations, between-individual variability effects, and cross-level interactions. Nightly objective changes in total sleep time, sleep efficiency, wake after sleep onset, and sleep onset latency were significantly associated with corresponding subjective-objective discrepancies. Subjective perception changed less than objective sleep parameters, suggesting reduced subjective responsiveness to nightly sleep changes. Between individuals, lower total sleep time variability was associated with greater bias in perceived sleep duration and sleep efficiency. Higher N2 percentage variability was associated with greater wake after sleep onset perception bias and moderated the association between objective wake time and subjective perception. These findings suggest that subjective sleep perception in chronic insomnia is influenced by nightly objective sleep changes and longer-term sleep variability. N2-related findings should be interpreted cautiously given the exploratory sleep-stage-specific analyses and portable EEG monitoring.
- 2 January 2026
- Published by Springer Nature
- p. 357-366
Multi-stage Interactive Audio-Visual Fusion for Parkinson’s Disease Assisted Diagnosis
- 2 January 2026
- Published by Springer Nature
- p. 357-366
Multi-stage Interactive Audio-Visual Fusion for Parkinson’s Disease Assisted Diagnosis
- Open Access
Dynamic Facial Expressions Analysis Based Parkinson's Disease Auxiliary Diagnosis
Parkinson's disease (PD), a prevalent neurodegenerative disorder, significantly affects patients' daily functioning and social interactions. To facilitate a more efficient and accessible diagnostic approach for PD, we propose a dynamic facial expression analysis-based PD auxiliary diagnosis method. This method targets hypomimia, a characteristic clinical symptom of PD, by analyzing two manifestations: reduced facial expressivity and facial rigidity, thereby facilitating the diagnosis process. We develop a multimodal facial expression analysis network to extract expression intensity features during patients' performance of various facial expressions. This network leverages the CLIP architecture to integrate visual and textual features while preserving the temporal dynamics of facial expressions. Subsequently, the expression intensity features are processed and input into an LSTM-based classification network for PD diagnosis. Our method achieves an accuracy of 93.1%, outperforming other in-vitro PD diagnostic approaches. This technique offers a more convenient detection method for potential PD patients, improving their diagnostic experience.
Open AccessDynamic Facial Expressions Analysis Based Parkinson's Disease Auxiliary Diagnosis
Parkinson's disease (PD), a prevalent neurodegenerative disorder, significantly affects patients' daily functioning and social interactions. To facilitate a more efficient and accessible diagnostic approach for PD, we propose a dynamic facial expression analysis-based PD auxiliary diagnosis method. This method targets hypomimia, a characteristic clinical symptom of PD, by analyzing two manifestations: reduced facial expressivity and facial rigidity, thereby facilitating the diagnosis process. We develop a multimodal facial expression analysis network to extract expression intensity features during patients' performance of various facial expressions. This network leverages the CLIP architecture to integrate visual and textual features while preserving the temporal dynamics of facial expressions. Subsequently, the expression intensity features are processed and input into an LSTM-based classification network for PD diagnosis. Our method achieves an accuracy of 93.1%, outperforming other in-vitro PD diagnostic approaches. This technique offers a more convenient detection method for potential PD patients, improving their diagnostic experience.
- Open Access
- 24 September 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 33 (15344320) , 3845-3855
Skeleton-Based Continuous Scale Parkinsonian Gait Score Estimation Using Omni-Dimensional Self-Attention Convolution Networks
Gait abnormalities constitute a primary motor symptom of Parkinson’s disease (PD). Clinically, the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) is widely recognized as the standard to evaluate gait impairment in PD. Recent skeleton-based methods have sought to estimate MDS-UPDRS gait scores, but most approaches treat score prediction as a coarse classification task, limiting their ability to capture subtle, progressive gait changes over time. These methods also often neglect clinical prior knowledge and fail to model localized gait features, leading to unsatisfactory performance. In addition, a continuous scale evaluation of gait impairment could result in a better formulation and adjustment of the treatment plan. In this paper, we introduce a novel framework for providing continuous-scale gait impairment estimation from the discrete annotation of MDS-UPDRS using skeleton data. First, we convert non-Euclidean skeleton information into two Euclidean spatiotemporal feature maps, ensuring a rigid spatial-temporal structure around the central joint. Next, we employ an omni-dimensional attention convolutional network to extract local spatiotemporal gait features within these normalized feature maps. We then integrate the features from both maps using an adaptive channel feature fusion module, capturing comprehensive gait information. Finally, we propose a numerical score prediction strategy that leverages MDS-UPDRS scores as anchors to predict gait impairment on a continuous scale without requiring continuous-scale annotations from clinicians. The effectiveness of the proposed approach is validated using a substantial clinical PD gait skeleton dataset.
- 24 September 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 33 (15344320) , 3845-3855
Open AccessSkeleton-Based Continuous Scale Parkinsonian Gait Score Estimation Using Omni-Dimensional Self-Attention Convolution Networks
Gait abnormalities constitute a primary motor symptom of Parkinson’s disease (PD). Clinically, the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) is widely recognized as the standard to evaluate gait impairment in PD. Recent skeleton-based methods have sought to estimate MDS-UPDRS gait scores, but most approaches treat score prediction as a coarse classification task, limiting their ability to capture subtle, progressive gait changes over time. These methods also often neglect clinical prior knowledge and fail to model localized gait features, leading to unsatisfactory performance. In addition, a continuous scale evaluation of gait impairment could result in a better formulation and adjustment of the treatment plan. In this paper, we introduce a novel framework for providing continuous-scale gait impairment estimation from the discrete annotation of MDS-UPDRS using skeleton data. First, we convert non-Euclidean skeleton information into two Euclidean spatiotemporal feature maps, ensuring a rigid spatial-temporal structure around the central joint. Next, we employ an omni-dimensional attention convolutional network to extract local spatiotemporal gait features within these normalized feature maps. We then integrate the features from both maps using an adaptive channel feature fusion module, capturing comprehensive gait information. Finally, we propose a numerical score prediction strategy that leverages MDS-UPDRS scores as anchors to predict gait impairment on a continuous scale without requiring continuous-scale annotations from clinicians. The effectiveness of the proposed approach is validated using a substantial clinical PD gait skeleton dataset.
- Open Access
- 18 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Integration of multi-omics quantitative trait loci evidence reveals novel susceptibility genes for Alzheimer’s disease
Alzheimer’s Disease (AD) is the leading cause of dementia globally, significantly impacting health and socio-economic sectors. Our study aims to elucidate the molecular basis of AD using an integrated multi-omics approach. We utilized a combination of genomics, transcriptomics, and proteomics data from multiple tissues (blood, cerebrospinal fluid and brain). Summary-data-based Mendelian Randomization (SMR), colocalization analysis and Heterogeneity in Dependent Instruments (HEIDI) analyses were conducted to establish causality between genetic variants and AD risk. Our results identified causal relationships across multiple omics layers, with significant findings for the Angiotensin-converting enzyme (ACE) and CD33 molecule (CD33) genes. For ACE, our analyses across methylation, expression, and protein levels revealed an overall odds ratio (OR) indicating a protective effect against AD. Specifically, increased methylation at cg04199256 and cg21657705 was associated with higher ACE expression. CD33 demonstrated an increased risk of AD (OR = 1.17, 95% CI: 1.09–1.25).Both genes showed strong colocalization signals, with ACE and CD33 having posterior probability values (PP.H4) of 0.99 and 0.95, respectively. The proteins TMEM106B (PP.H4 = 0.96), SIRPA (PP.H4 = 0.92), CTSH (PP.H4 = 0.77), and CLN5 (PP.H4 = 0.92) also showed strong colocalization evidence. At the protein level, genetically predicted higher levels of TMEM106B (OR 1.44, 95% CI 1.24–1.68), SIRPA (OR 1.03, 95% CI 1.02–1.04) and CTSH (OR 1.04, 95% CI 1.03–1.06) was associated with an increased risk of AD; genetically predicted higher level of CLN5 were inversely associated with AD risk (OR 0.69, 95% CI 0.58–0.83). By identifying multiple candidate targets and regulatory axes, our findings offer a valuable resource for prioritizing genes for functional validation and advancing future therapeutic development.
- 18 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Open AccessIntegration of multi-omics quantitative trait loci evidence reveals novel susceptibility genes for Alzheimer’s disease
Alzheimer’s Disease (AD) is the leading cause of dementia globally, significantly impacting health and socio-economic sectors. Our study aims to elucidate the molecular basis of AD using an integrated multi-omics approach. We utilized a combination of genomics, transcriptomics, and proteomics data from multiple tissues (blood, cerebrospinal fluid and brain). Summary-data-based Mendelian Randomization (SMR), colocalization analysis and Heterogeneity in Dependent Instruments (HEIDI) analyses were conducted to establish causality between genetic variants and AD risk. Our results identified causal relationships across multiple omics layers, with significant findings for the Angiotensin-converting enzyme (ACE) and CD33 molecule (CD33) genes. For ACE, our analyses across methylation, expression, and protein levels revealed an overall odds ratio (OR) indicating a protective effect against AD. Specifically, increased methylation at cg04199256 and cg21657705 was associated with higher ACE expression. CD33 demonstrated an increased risk of AD (OR = 1.17, 95% CI: 1.09–1.25).Both genes showed strong colocalization signals, with ACE and CD33 having posterior probability values (PP.H4) of 0.99 and 0.95, respectively. The proteins TMEM106B (PP.H4 = 0.96), SIRPA (PP.H4 = 0.92), CTSH (PP.H4 = 0.77), and CLN5 (PP.H4 = 0.92) also showed strong colocalization evidence. At the protein level, genetically predicted higher levels of TMEM106B (OR 1.44, 95% CI 1.24–1.68), SIRPA (OR 1.03, 95% CI 1.02–1.04) and CTSH (OR 1.04, 95% CI 1.03–1.06) was associated with an increased risk of AD; genetically predicted higher level of CLN5 were inversely associated with AD risk (OR 0.69, 95% CI 0.58–0.83). By identifying multiple candidate targets and regulatory axes, our findings offer a valuable resource for prioritizing genes for functional validation and advancing future therapeutic development.
- 5 February 2025
- Published by Springer Nature
- p. 457-469
Diagnosis of Parkinson’s Disease Based on Machine Learning Model Using Eye Tracking
- 5 February 2025
- Published by Springer Nature
- p. 457-469
Diagnosis of Parkinson’s Disease Based on Machine Learning Model Using Eye Tracking